Literature DB >> 30220887

OPTIMIZATION OF SCALE-UP SYNTHESIS OF ANTI-CANCER CERAMIDE ANALOG 315.

Maryam Foroozesh1, Navneet Goyal1, Taylor Jackson1, Camilla Do1, Sydney Booker1, Tarius Hill1, Jiawang Liu1.   

Abstract

Ceramides, serve as central mediators in sphingolipid metabolism and signaling pathways. They function in signaling events which induce apoptosis, cell cycle arrest, and autophagic responses. In cancer cells, ceramide levels are often suppressed by the up-regulation of ceramide-metabolizing enzymes or the down-regulation of ceramide-generating enzymes, resulting in increased cancer cell survival. Chemotherapeutic drugs and radiation therapy have been shown to increase intracellular ceramide levels leading to anti-cancer effects. Anti-cancer effects have also been seen in cancer cells with the use of exogenous short-chain ceramides. Our laboratory has synthesized a library of ceramide analogs and tested their effects on breast cancer cell lines. Analog 315 has been shown to be the most effective ceramide analog in our library. Here, we are reporting a large-scale synthesis of that analog is reported.

Entities:  

Keywords:  Breast Cancer; Ceramide; Chemo-Therapy; Drug-Resistance; Sphingolipid

Year:  2017        PMID: 30220887      PMCID: PMC6138050     

Source DB:  PubMed          Journal:  J Undergrad Chem Res        ISSN: 1541-6003


  14 in total

1.  Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.

Authors:  Christopher B Weldon; Amanda P Parker; Daniel Patten; Steven Elliott; Yan Tang; Daniel E Frigo; Christine M Dugan; Erin L Coakley; Nancy N Butler; John L Clayton; Jawed Alam; Tyler J Curiel; Barbara S Beckman; Bernard M Jaffe; Matthew E Burow
Journal:  Int J Oncol       Date:  2004-06       Impact factor: 5.650

Review 2.  Glycosphingolipids and drug resistance.

Authors:  Valerie Gouaze-Andersson; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2006-08-26

Review 3.  Inhibitors of sphingolipid metabolism enzymes.

Authors:  Antonio Delgado; Josefina Casas; Amadeu Llebaria; José Luís Abad; Gemma Fabrias
Journal:  Biochim Biophys Acta       Date:  2006-09-01

4.  Novel D: -erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics.

Authors:  James W Antoon; Jiawang Liu; Adharsh P Ponnapakkam; Matthew M Gestaut; Maryam Foroozesh; Barbara S Beckman
Journal:  Cancer Chemother Pharmacol       Date:  2010-02-14       Impact factor: 3.333

Review 5.  Sphingosine 1-phosphate and cancer.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Nat Rev Cancer       Date:  2010-06-17       Impact factor: 60.716

6.  Novel anti-viability ceramide analogs: design, synthesis, and structure-activity relationship studies of substituted (S)-2-(benzylideneamino)-3-hydroxy-N-tetradecylpropanamides.

Authors:  Jiawang Liu; James W Antoon; Adharsh Ponnapakkam; Barbara S Beckman; Maryam Foroozesh
Journal:  Bioorg Med Chem       Date:  2010-06-08       Impact factor: 3.641

Review 7.  A review of ceramide analogs as potential anticancer agents.

Authors:  Jiawang Liu; Barbara S Beckman; Maryam Foroozesh
Journal:  Future Med Chem       Date:  2013-08       Impact factor: 3.808

8.  In vitro and in vivo induction of apoptosis by sphingosine and N, N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells.

Authors:  T Shirahama; E A Sweeney; C Sakakura; A K Singhal; K Nishiyama; S Akiyama; S Hakomori; Y Igarashi
Journal:  Clin Cancer Res       Date:  1997-02       Impact factor: 12.531

Review 9.  Roles of bioactive sphingolipids in cancer biology and therapeutics.

Authors:  Sahar A Saddoughi; Pengfei Song; Besim Ogretmen
Journal:  Subcell Biochem       Date:  2008

10.  LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria.

Authors:  Thomas H Beckham; Ping Lu; Elizabeth E Jones; Tucker Marrison; Clayton S Lewis; Joseph C Cheng; Venkat K Ramshesh; Gyda Beeson; Craig C Beeson; Richard R Drake; Alicja Bielawska; Jacek Bielawski; Zdzislaw M Szulc; Besim Ogretmen; James S Norris; Xiang Liu
Journal:  J Pharmacol Exp Ther       Date:  2012-10-18       Impact factor: 4.030

View more
  2 in total

1.  Acute toxicity evaluation of a novel ceramide analog for the treatment of breast cancer.

Authors:  Tulasi Ponnapakkam; Kyla Bongay-Williams; Teresa Beamon; Royce Hooks; Degrick Cheatham; Navneet Goyal; Muralidharan Anbalagan; Maryam Foroozesh
Journal:  Toxicol Rep       Date:  2021-07-31

2.  Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma.

Authors:  Jungang Chen; Navneet Goyal; Lu Dai; Zhen Lin; Luis Del Valle; Jovanny Zabaleta; Jiawang Liu; Steven R Post; Maryam Foroozesh; Zhiqiang Qin
Journal:  Blood       Date:  2020-11-05       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.